Characteristics of children with follow-up data available (n=460 unless otherwise stated)
| Median ACT score in children >11 years (IQR) (n=75) | 22 (19–24) |
| Median CACT score in children ≤11 years (IQR) (n=100) | 23 (21 to 25) |
| Number of children with ACT/CACT <20 (%) (n=175) | 43 (25) |
| No. of children with ≥1 asthma attacks in following 6 months (%) | 75 (16) |
| No. of children prescribed ≥1 inhaled corticosteroid in following 6 months (%) | 311 (68) |
| No. of children prescribed ≥1 SABA inhaler in following 6 months (%) | 322 (70) |
| No. of children prescribed no ICS or SABA in following 6 months (%) | 99 (22) |
| Mean asthma medication ratio (AMR) in following 6 months (95% CI, range) | 0.60 (0.57 to 0.63, 0–1) |
| Change in AMR from baseline to follow-up | |
| Number (%) of children with: | |
| No change to AMR | 122 (27) |
| Increased AMR | 192 (42) |
| Decreased AMR | 146 (32) |
ACT, asthma control test; CACT, childhood asthma control test; ICS, inhaled corticosteroids; SABA, short acting beta-2 agonist.